유해화학물질 노출 근로자의 대사증후군 발생위험에 대한 epinephrine과 norepinephrine의 영향

목차 (Table of Contents)

• Ⅰ. 서론
• Ⅱ. 연구 방법
• 1. 연구 대상
• 2. 연구도구 및 분석방법
• 3. 자료 분석
• Ⅲ. 연구 결과
• 1. 대상자의 일반적 특성
• 2. 노출군 대상자의 유해화학물질 노출농도
• 3. 대사증후군 진단지표, epinephrine 및 norepinephrine 수준 비교
• 4. 유해화학물질의 노출농도와 EP 및 NEP의 상관관계 및 대사증후군 진단지표와의 관련성
• Ⅳ. 논의
• Ⅴ. 결론
• 참고문헌
• Abstract

참고문헌 (Reference)

1 이현진, "보건소 비만 프로그램을 통한 성인 여성의 체지방 변화에 따른 건강상태 및 식생활 비교" 단국대학교 2007

2 허경화, "만성적인 스티렌 노출 근로자에 있어 대사증후군 유발에 관여하는 위험요인의 생리적 수준 변화" 한국산업위생학회 19 (19): 30-38, 2009

3 National Cholesterol Education Program's Adult Treatment Panel III Report, "Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adults Treatment Panel III) final report" 106 : 3143-3421, 2002

4 Merker, G. H., "TH1-directed modulation of in vitro cytokine production in human peripheral blood mononuclear cells by styrene-7-8oxide" 160 : 105-111, 2006

5 Chakrabarti, S. K., "Styrene and styrene oxide affect the transport of dopamine in purified rat striatal synaptic vesicles" 255 : 70-74, 1999

6 Kotseva, K., "Study of the cardiovascular effects of occupational exposure to organic solvents" 71 : S87-S91, 1998

7 Ogata, M., "Simultaneous determination of urinary creatinine and metabolites of toluene, xylene, ethylbenzene and phenol by automated high performance liquid chromatography" 61 : 131-140, 1988

8 Landsberg, L., "Obesity, blood pressure and the sympathetic nervous system" 1 : 295-303, 1991

9 Kohm, A. P., "Norepinephrine: A messenger from the brain to the immune system" 21 (21): 539-542, 2000

10 Marie, S., "Norepinephrine- and epinephrinedeficient mice gain weight normally on a high-fat diet" 13 (13): 1518-1522, 2005

11 Sepalainen, A. M., "Neurophysiological findings among workers occupationally exposed to styrene" 3 : 140-146, 1976

12 NIOSH, "NIOSH manual of analytical methods, 4th ed." U.S. Department of Health and Human Services 1996

13 DeFronzo, R. A., "Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease" 14 : 173-194, 1991

14 Qiu, Y., "Immunoregulatory role of neurotransmitters" 6 : 223-231, 1996

15 Gillis, B., "Identification of human cell responses" 90 : 324-333, 2007

16 Haffner, S. M., "Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in nondiabetics" 37 : 338-345, 1988

17 Woods, S. C., "Hormonal mediation of energy homeostasis in obesity, diabetes and related disorders" 2 (2): 321-326, 2005

18 Cryer, P. E., "Glucose counterregulation: Prevention and correction of hypoglycemia in humans" 264 : E149-155, 1993

19 Bao. X., "Epinephrine is required for normal cardiovascular responses to stress in the phenylethanolamine N-methyltransferase knockout mouse" 116 (116): 1024-1031, 2007

20 Khanna, V. K., "Effect of protein malnutrition on the neurobehavioural toxicity of styrene in young rats" 14 : 351-356, 1994

21 Graff, J. E., "Disassociation of carbon disulfide-induced depression of flash-evoked poteitial peak N166 amplitude and norepinephrine levels" 73 (73): 403-415, 2003

22 Kleinridders, A., "CNS-targets in control of energy and glucose homeostasis" 9 : 794-804, 2009

23 Ames, A., "CNS energy metabolism as regulated to function" 34 : 42-68, 2000

24 Mutti, A., "Brain dopamine as a target for solvent toxicity: Effects of some monocyclic aromatic hydrocarbons" 49 : 77-82, 1988

25 Lima, J. J., "Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations" 56 : 757-765, 2007

26 Albright, J. A., "Airborne pollutants and the immune system" 114 : 232-238, 1996

27 Carvalho, D., "A new derivatization procedure for the analysis of hippuric acid and methyl hippuric acid by gaschromatography" 63 : 33-37, 1991